Authors:
Lakhani, SR
Gusterson, BA
Jacquemier, J
Sloane, JP
Anderson, TJ
van de Vijver, MJ
Venter, D
Freeman, A
Antoniou, A
McGuffog, L
Smyth, E
Steel, CM
Haites, N
Scott, RJ
Goldgar, D
Neuhausen, S
Daly, PA
Ormiston, W
McManus, R
Scherneck, S
Ponder, BAJ
Futreal, PA
Peto, J
Stoppa-Lyonnet, D
Bignon, YJ
Struewing, JP
Bishop, DT
Klijn, JGM
Devilee, P
Cornelisse, CJ
Lasset, C
Lenoir, G
Barkardottir, RB
Egilsson, V
Hamann, U
Chang-Claude, J
Sobol, H
Weber, B
Easton, DF
Stratton, MR
Citation: Sr. Lakhani et al., The pathology of familial breast cancer: Histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2, CLIN CANC R, 6(3), 2000, pp. 782-789
Authors:
Cardiff, RD
Anver, MR
Gusterson, BA
Hennighausen, L
Jensen, RA
Merino, MJ
Rehm, S
Russo, J
Tavassoli, FA
Wakefield, LM
Ward, JM
Green, JE
Citation: Rd. Cardiff et al., The mammary pathology of genetically engineered mice: the consensus reportand recommendations from the Annapolis meeting, ONCOGENE, 19(8), 2000, pp. 968-988
Citation: Ba. Howard et Ba. Gusterson, The characterization of a mouse mutant that displays abnormal mammary gland development, MAMM GENOME, 11(3), 2000, pp. 234-237
Citation: Ba. Howard et Ba. Gusterson, Mammary gland patterning in the AXB/BXA recombinant inbred strains of mouse, MECH DEVEL, 91(1-2), 2000, pp. 305-309
Authors:
Naylor, S
Smalley, MJ
Robertson, D
Gusterson, BA
Edwards, PAW
Dale, TC
Citation: S. Naylor et al., Retroviral expression of Wnt-1 and Wnt-7b produces different effects in mouse mammary epithelium, J CELL SCI, 113(12), 2000, pp. 2129-2138
Authors:
Smith, PD
Crossland, S
Parker, G
Osin, P
Brooks, L
Waller, J
Philp, E
Crompton, MR
Gusterson, BA
Allday, MJ
Crook, T
Citation: Pd. Smith et al., Novel p53 mutants selected in BRCA-associated tumours which dissociate transformation suppression from other wild-type p53 functions, ONCOGENE, 18(15), 1999, pp. 2451-2459
Authors:
Williams, JA
Stone, EM
Millar, BC
Gusterson, BA
Grover, PL
Phillips, DH
Citation: Ja. Williams et al., Determination of the enzymes responsible for activation of the heterocyclic amine 2-amino-3-methylimidazo [4,5-f]quinoline in the human breast, PHARMACOGEN, 8(6), 1998, pp. 519-528